Filed under: microarray | Tagged: Clinical Research Organization, CRO | Leave a Comment »
trends in the life sciences and pharma research and development outsourcing (RDO)
Posted on November 24, 2010 by Albin Paul
Vicki Phelan, Managing Director, Pharmaceutical and Life Sciences Practice with Stan Lepeak, Managing Director, Global Research Trends in the life sciences and pharma research and development outsourcing (RDO) The complete report is available at http://goo.gl/MgVBu
Filed under: clinical research, Clinical Trial | Tagged: clinical research, clinical research organizatio, Clinical Trial, CRO, Drug Development, drug discovery, outsourcing | 1 Comment »
First Chinese Clinical Research Outsourcing Industry Standard Under Development
Posted on October 27, 2009 by Albin Paul
According to information from the The Contract Research Organization Union China (CROU) under the China National Pharmaceutical Technology Market Association, it is developing the first industry standard for the Chinese CRO sector, Guidelines for Clinical Trial Services of Contract Research Organizations. Currently drafting of the document is already completed and it is likely to be [...]
Filed under: microarray | Tagged: China, clinical research, Clinical Research Organization, Clinical Trial, Contract Research Organization, CRO, Drug Administration, GCP, ICH_GCP | 3 Comments »
Multi National Pharma sell their Captive Clinical Research Facilities in India
Posted on October 23, 2009 by Albin Paul
MNC pharma companies to control 8% of $20bn worth Indian medicines market by 2015. According to a FICCI study more than 60% of trials in India is conducted by Global Big Pharma companies. Indian Clinical Research arena is often compared to the Indian outsourcing success and hte wave of BPO industry success in India. Multi [...]
Filed under: microarray | Tagged: Clinical Trial, CRO, Drug Safety, Evidence based pharmacotherapy, health sciences global business unit, HSGBU, Indian CRO, oracle, Oracle health sciences global business unit, Pharmacoecconomics, Pharmacoepidemiology, Pharmacogenomics, pharmacovigilance | Leave a Comment »
